280 related articles for article (PubMed ID: 22745173)
1. Canonical Wnt suppressor, Axin2, promotes colon carcinoma oncogenic activity.
Wu ZQ; Brabletz T; Fearon E; Willis AL; Hu CY; Li XY; Weiss SJ
Proc Natl Acad Sci U S A; 2012 Jul; 109(28):11312-7. PubMed ID: 22745173
[TBL] [Abstract][Full Text] [Related]
2. A Wnt-Axin2-GSK3beta cascade regulates Snail1 activity in breast cancer cells.
Yook JI; Li XY; Ota I; Hu C; Kim HS; Kim NH; Cha SY; Ryu JK; Choi YJ; Kim J; Fearon ER; Weiss SJ
Nat Cell Biol; 2006 Dec; 8(12):1398-406. PubMed ID: 17072303
[TBL] [Abstract][Full Text] [Related]
3. Esculetin suppresses tumor growth and metastasis by targeting Axin2/E-cadherin axis in colorectal cancer.
Kim WK; Byun WS; Chung HJ; Oh J; Park HJ; Choi JS; Lee SK
Biochem Pharmacol; 2018 Jun; 152():71-83. PubMed ID: 29534875
[TBL] [Abstract][Full Text] [Related]
4. Activation of AXIN2 expression by beta-catenin-T cell factor. A feedback repressor pathway regulating Wnt signaling.
Leung JY; Kolligs FT; Wu R; Zhai Y; Kuick R; Hanash S; Cho KR; Fearon ER
J Biol Chem; 2002 Jun; 277(24):21657-65. PubMed ID: 11940574
[TBL] [Abstract][Full Text] [Related]
5. p53 regulates nuclear GSK-3 levels through miR-34-mediated Axin2 suppression in colorectal cancer cells.
Kim NH; Cha YH; Kang SE; Lee Y; Lee I; Cha SY; Ryu JK; Na JM; Park C; Yoon HG; Park GJ; Yook JI; Kim HS
Cell Cycle; 2013 May; 12(10):1578-87. PubMed ID: 23624843
[TBL] [Abstract][Full Text] [Related]
6. Nuclear AXIN2 represses MYC gene expression.
Rennoll SA; Konsavage WM; Yochum GS
Biochem Biophys Res Commun; 2014 Jan; 443(1):217-22. PubMed ID: 24299953
[TBL] [Abstract][Full Text] [Related]
7. CDX2 inhibits the proliferation and tumor formation of colon cancer cells by suppressing Wnt/β-catenin signaling via transactivation of GSK-3β and Axin2 expression.
Yu J; Liu D; Sun X; Yang K; Yao J; Cheng C; Wang C; Zheng J
Cell Death Dis; 2019 Jan; 10(1):26. PubMed ID: 30631044
[TBL] [Abstract][Full Text] [Related]
8. [Mechanism of Wnt signaling pathway regulation by a truncated mutant of Axin2 in colorectal cancer].
Wang FW; Wen L; Zhu SW; Yao Q; Cai YM; Ma G
Ai Zheng; 2007 Oct; 26(10):1041-6. PubMed ID: 17927870
[TBL] [Abstract][Full Text] [Related]
9. Regulation of APC and AXIN2 expression by intestinal tumor suppressor CDX2 in colon cancer cells.
Olsen AK; Coskun M; Bzorek M; Kristensen MH; Danielsen ET; Jørgensen S; Olsen J; Engel U; Holck S; Troelsen JT
Carcinogenesis; 2013 Jun; 34(6):1361-9. PubMed ID: 23393221
[TBL] [Abstract][Full Text] [Related]
10. The inhibition of Wnt/beta-catenin signalling by 1alpha,25-dihydroxyvitamin D3 is abrogated by Snail1 in human colon cancer cells.
Larriba MJ; Valle N; Pálmer HG; Ordóñez-Morán P; Alvarez-Díaz S; Becker KF; Gamallo C; de Herreros AG; González-Sancho JM; Muñoz A
Endocr Relat Cancer; 2007 Mar; 14(1):141-51. PubMed ID: 17395983
[TBL] [Abstract][Full Text] [Related]
11. Endothelin-1 promotes epithelial-to-mesenchymal transition in human ovarian cancer cells.
Rosanò L; Spinella F; Di Castro V; Nicotra MR; Dedhar S; de Herreros AG; Natali PG; Bagnato A
Cancer Res; 2005 Dec; 65(24):11649-57. PubMed ID: 16357176
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D and Wnt/beta-catenin pathway in colon cancer: role and regulation of DICKKOPF genes.
Pendás-Franco N; Aguilera O; Pereira F; González-Sancho JM; Muñoz A
Anticancer Res; 2008; 28(5A):2613-23. PubMed ID: 19035286
[TBL] [Abstract][Full Text] [Related]
13. IWR-1 inhibits epithelial-mesenchymal transition of colorectal cancer cells through suppressing Wnt/β-catenin signaling as well as survivin expression.
Lee SC; Kim OH; Lee SK; Kim SJ
Oncotarget; 2015 Sep; 6(29):27146-59. PubMed ID: 26450645
[TBL] [Abstract][Full Text] [Related]
14. Sox17 and Sox4 differentially regulate beta-catenin/T-cell factor activity and proliferation of colon carcinoma cells.
Sinner D; Kordich JJ; Spence JR; Opoka R; Rankin S; Lin SC; Jonatan D; Zorn AM; Wells JM
Mol Cell Biol; 2007 Nov; 27(22):7802-15. PubMed ID: 17875931
[TBL] [Abstract][Full Text] [Related]
15. Oncogenic KRAS signalling promotes the Wnt/β-catenin pathway through LRP6 in colorectal cancer.
Lemieux E; Cagnol S; Beaudry K; Carrier J; Rivard N
Oncogene; 2015 Sep; 34(38):4914-27. PubMed ID: 25500543
[TBL] [Abstract][Full Text] [Related]
16. Role of Wnt/beta-catenin signaling pathway in epithelial-mesenchymal transition of human prostate cancer induced by hypoxia-inducible factor-1alpha.
Jiang YG; Luo Y; He DL; Li X; Zhang LL; Peng T; Li MC; Lin YH
Int J Urol; 2007 Nov; 14(11):1034-9. PubMed ID: 17956532
[TBL] [Abstract][Full Text] [Related]
17. miR-544a induces epithelial-mesenchymal transition through the activation of WNT signaling pathway in gastric cancer.
Yanaka Y; Muramatsu T; Uetake H; Kozaki K; Inazawa J
Carcinogenesis; 2015 Nov; 36(11):1363-71. PubMed ID: 26264654
[TBL] [Abstract][Full Text] [Related]
18. Mutations of the Wnt antagonist AXIN2 (Conductin) result in TCF-dependent transcription in medulloblastomas.
Koch A; Hrychyk A; Hartmann W; Waha A; Mikeska T; Waha A; Schüller U; Sörensen N; Berthold F; Goodyer CG; Wiestler OD; Birchmeier W; Behrens J; Pietsch T
Int J Cancer; 2007 Jul; 121(2):284-91. PubMed ID: 17373666
[TBL] [Abstract][Full Text] [Related]
19. A diterpenoid derivative 15-oxospiramilactone inhibits Wnt/β-catenin signaling and colon cancer cell tumorigenesis.
Wang W; Liu H; Wang S; Hao X; Li L
Cell Res; 2011 May; 21(5):730-40. PubMed ID: 21321609
[TBL] [Abstract][Full Text] [Related]
20. Formation of Tankyrase Inhibitor-Induced Degradasomes Requires Proteasome Activity.
Pedersen NM; Thorvaldsen TE; Schultz SW; Wenzel EM; Stenmark H
PLoS One; 2016; 11(8):e0160507. PubMed ID: 27482906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]